Paper36765747
Gene-Transcript Expression in Urine Supernatant and Urine Cell-Sediment Are Different but Equally Useful for Detecting Prostate Cancer.
Yazbek Hanna M and 8 others. Cancers (Basel), 2023. Cited by 8 papers, by iCite.
Cite this record
ConductScience Library. Gene-Transcript Expression in Urine Supernatant and Urine Cell-Sediment Are Different but Equally Useful for Detecting Prostate Cancer. Papers, record 36765747. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36765747
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Gene-Transcript Expression in Urine Supernatant and Urine Cell-Sediment Are Different but Equally Useful for Detecting Prostate Cancer.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants8
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| GAP1 Urine Biomarkers | Movember Foundation | PubMed | ||
| RIA18-ST2-014 | Prostate Cancer UK | United Kingdom | PubMed | |
| NA | The Masonic Charitable Foundation | PubMed | ||
| NA | The Bob Champion Cancer Trust | PubMed | ||
| NA | the King family | PubMed | ||
| 19-07R | Big C Cancer Charity | PubMed | ||
| NA | The Andy Ripley Memorial Fund | PubMed | ||
| NA | the Stephen Hargrave Trust | PubMed |
Source PubMed
References66
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 23086769 | Correlation of urine TMPRSS2:ERG and PCA3 to ERG+ and total prostate cancer burden. | Am J Clin Pathol | 2012 | https://conductscience.org/library/papers/23086769 | PubMed |
| 2 | 33941866 | Clinical use of the SelectMDx urinary-biomarker test with or without mpMRI in prostate cancer diagnosis: a prospective, multicenter study in biopsy-naïve men. | Prostate Cancer Prostatic Dis | 2021 | https://conductscience.org/library/papers/33941866 | PubMed |
| 3 | 7943281 | The Na-K-Cl cotransporters. | Am J Physiol | 1994 | https://conductscience.org/library/papers/7943281 | PubMed |
| 4 | 27144529 | Urine Exosomes for Non-Invasive Assessment of Gene Expression and Mutations of Prostate Cancer. | PLoS One | 2016 | https://conductscience.org/library/papers/27144529 | PubMed |
| 5 | 16254181 | Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. | Science | 2005 | https://conductscience.org/library/papers/16254181 | PubMed |
| 6 | 17878933 | Evidence based selection of housekeeping genes. | PLoS One | 2007 | https://conductscience.org/library/papers/17878933 | PubMed |
| 7 | 20428099 | Nucleic acids within urinary exosomes/microvesicles are potential biomarkers for renal disease. | Kidney Int | 2010 | https://conductscience.org/library/papers/20428099 | PubMed |
| 8 | 24211598 | Prostate cancer biomarker profiles in urinary sediments and exosomes. | J Urol | 2014 | https://conductscience.org/library/papers/24211598 | PubMed |
| 9 | 21394175 | Prostate cancer: diagnostic performance of the PCA3 urine test. | Nat Rev Urol | 2011 | https://conductscience.org/library/papers/21394175 | PubMed |
| 10 | 9846985 | Uroplakin gene expression by normal and neoplastic human urothelium. | Am J Pathol | 1998 | https://conductscience.org/library/papers/9846985 | PubMed |
| 11 | 24379839 | Expression of CD26 and CXCR4 in prostate carcinoma and its relationship with clinical parameters. | J Res Med Sci | 2013 | https://conductscience.org/library/papers/24379839 | PubMed |
| 12 | 25405282 | BTG2: a rising star of tumor suppressors (review). | Int J Oncol | 2015 | https://conductscience.org/library/papers/25405282 | PubMed |
| 13 | 29719090 | Apolipoprotein C1 promotes prostate cancer cell proliferation in vitro. | J Biochem Mol Toxicol | 2018 | https://conductscience.org/library/papers/29719090 | PubMed |
| 14 | 17043636 | Diversity of TMPRSS2-ERG fusion transcripts in the human prostate. | Oncogene | 2007 | https://conductscience.org/library/papers/17043636 | PubMed |
| 15 | 25788493 | Identification of a Candidate Gene Panel for the Early Diagnosis of Prostate Cancer. | Clin Cancer Res | 2015 | https://conductscience.org/library/papers/25788493 | PubMed |
| 16 | 28881605 | Low PCA3 expression is a marker of poor differentiation in localized prostate tumors: exploratory analysis from 12,076 patients. | Oncotarget | 2017 | https://conductscience.org/library/papers/28881605 | PubMed |
| 17 | 28110982 | Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study. | Lancet | 2017 | https://conductscience.org/library/papers/28110982 | PubMed |
| 18 | 26310814 | The role of HOXC6 in prostate cancer development. | Prostate | 2015 | https://conductscience.org/library/papers/26310814 | PubMed |
| 19 | 11788820 | Recruitment and activation of caspase-8 by the Huntingtin-interacting protein Hip-1 and a novel partner Hippi. | Nat Cell Biol | 2002 | https://conductscience.org/library/papers/11788820 | PubMed |
| 20 | 26630694 | Comparative analysis of prostate cancer specific biomarkers PCA3 and ERG in whole urine, urinary sediments and exosomes. | Clin Chem Lab Med | 2016 | https://conductscience.org/library/papers/26630694 | PubMed |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42985552 | Urine sediment (uSed) in molecular diagnosis of genitourinary cancer: From materials to methods. | J Liq Biopsy | 2026 | https://conductscience.org/library/papers/42985552 | PubMed |
| 41968196 | Comparison of prostate cancer diagnostic models based on PCA3 and TMPRSS2:ERG RNA biomarkers from post-DRE and non-DRE urine specimens. | World J Urol | 2026 | https://conductscience.org/library/papers/41968196 | PubMed |
| 41598250 | Non-Coding RNA Biomarkers in Prostate Cancer: Evidence Mapping and In Silico Characterization. | Life (Basel) | 2026 | https://conductscience.org/library/papers/41598250 | PubMed |
| 39859516 | Exosomal Liquid Biopsy in Prostate Cancer: A Systematic Review of Biomarkers for Diagnosis, Prognosis, and Treatment Response. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/39859516 | PubMed |
| 39215852 | Exploring the prognosis value, immune correlation, and drug responsiveness prediction of homeobox C6 (HOXC6) in lung adenocarcinoma. | Discov Oncol | 2024 | https://conductscience.org/library/papers/39215852 | PubMed |
| 38818039 | A panel based on three-miRNAs as diagnostic biomarker for prostate cancer. | Front Genet | 2024 | https://conductscience.org/library/papers/38818039 | PubMed |
| 37627171 | Editorial: The Application of Proteogenomics to Urine Analysis for the Identification of Novel Biomarkers of Prostate Cancer: An Exploratory Study. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/37627171 | PubMed |
Genes31
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36765747
GET https://conductscience.org/api/papers/v1/36765747/references?page=2